ARTS WAY MANUFACTURING CO INC SEC Filings

Matthew Westendorf, a director of Arts-Way Manufacturing Co Inc (ARTW), was granted 1,000 fully-vested restricted shares on 08/31/2025 at a reported price of $0 under the director compensation plan. Following the award, Westendorf's beneficial ownership increased to 26,000 shares. The Form 4 was filed as a single reporting person filing and was signed by an attorney-in-fact.

Randall C. Ramsey, a director of Arts-Way Manufacturing Co., received 1,000 fully vested restricted shares on 08/31/2025 under the company's director compensation plan. The transaction was reported on a Form 4 filed pursuant to Section 16. Following the grant, Mr. Ramsey beneficially owns 72,709 shares of the issuer's common stock, held in a direct capacity.

The reported shares were granted at a $0 purchase price and are described as fully vested restricted stock. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Ramsey and contains an explanation that the award represents director compensation.

Thomas E. Buffamante, a director of Arts-Way Manufacturing Co., acquired 1,000 shares of common stock on 08/31/2025 as fully-vested restricted stock under the company's director compensation plan. The transaction shows a $0 price for the grant and increases his beneficial ownership to 58,000 shares, reported as direct ownership. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on the same date. The filing does not disclose derivative transactions, amendments, or additional cash consideration.

Art’s-Way Manufacturing Co., Inc. filed an amendment to update governance information from its 2025 Annual Meeting of Stockholders. The Board of Directors has decided that stockholders will continue to cast non-binding, advisory votes on the compensation of the company’s named executive officers every year.

This decision follows the stockholders’ prior non-binding recommendation in favor of an annual “say-on-pay” frequency and is consistent with the company’s earlier proxy recommendation. The company states that this annual advisory vote schedule will remain in place until the next required stockholder vote on frequency, which must occur no later than the 2031 Annual Meeting of Stockholders.

Michael W. Woods, identified as an officer and director of Arts-Way Manufacturing Co., reported two open-market sales of common stock: 4,074 shares sold at $3.769 on 08/06/2025 and 5,525 shares sold at $4.0501 on 08/07/2025. After the first reported sale his beneficial ownership was reported as 32,524 shares, and following the second sale it was 26,999 shares.

The filing also explains the composition of those holdings: portions are fully vested shares and portions are restricted stock subject to staged forfeiture-lapse schedules, with multiple tranches vesting on dates described in the form. No derivative securities were reported on this form.

Arts-Way Manufacturing Co. Inc. (ARTW) filed a Form 144 disclosing an insider’s plan to sell 5,525 common shares through NASDAQ on 08/07/2025. At an aggregate market value of $22,376.80 (~$4.05/sh), the proposed sale equals 17.1 % of the 32,254 shares outstanding stated in the notice.

The stock was acquired via four stock-award grants: 1,022 shares on 01/31/2020 and three blocks of 1,501 shares each in January 2024. The filer—identified as Michael Woods in the recent-sales table—already sold 11,666 shares during the past three months, generating $40,488.23 in gross proceeds (7,592 shares on 07/29/2025 and 4,074 shares on 08/06/2025). Should the new sale proceed, insider dispositions over the period would total 17,191 shares, or 53.3 % of the shares outstanding.

The signing party affirms no undisclosed material adverse information. While the dollar amount is modest, the large percentage of shares involved may increase float and exert supply pressure, meriting close investor attention.

Arts-Way Manufacturing (ARTW) Chief Financial Officer Michael W. Woods reported an open-market sale of 7,592 common shares on 07/29/2025, according to a Form 4 filed 07/31/2025. The shares were sold at an average price of $3.3105, yielding roughly $25,150 in gross proceeds.

After the transaction, Woods’ direct holding stands at 36,597 shares. The position consists of 17,598 fully-vested shares and 18,999 restricted shares scheduled to vest between January 2026 and January 2028, indicating continued long-term exposure.

The disposal represents an estimated 17% reduction from his prior 44,189-share stake. No derivative securities were bought or sold, and no other insiders are listed in the filing.

Art’s-Way Manufacturing (ARTW) reported Q2 FY 2025 results (ended 31 May 2025) that show a sharp swing to profitability driven by a one-time Employee Retention Credit (ERC) refund, while core operations delivered mixed performance.

Income statement highlights

• Quarterly sales fell 5.8 % to $6.34 million; six-month sales down 7.8 % to $11.48 million.
• Gross profit rose 8.0 % to $2.06 million; margin expanded to 32.5 % (28.3 % last year) on better cost control and a richer mix in Modular Buildings.
• Operating income improved to $0.51 million (vs. $0.17 million). Six-month operating income of $0.51 million reversed a $0.21 million loss in FY 2024.
• Other income of $1.46 million reflects ERC refunds (net of $0.41 million consulting fees), lifting pre-tax income to $1.88 million.
• Net income from continuing operations reached $1.48 million (EPS $0.29) versus a small loss last year; six-month net income $1.43 million versus a $0.43 million loss.

Segment performance

• Agricultural Products: Revenue down 11.6 % to $4.03 million; operating loss $0.05 million. Management cites weak row-crop prices and high rates; expects destocking to bottom within 12–18 months.
• Modular Buildings: Revenue up 6.3 % to $2.31 million; operating income surged to $0.56 million with 41.7 % margin as large laboratory projects finished below budget.

Balance sheet & liquidity

• Cash rose to $4,534; line-of-credit balance cut to $1.06 million (from $1.93 million).
• Total liabilities fell 21 % to $7.26 million; equity climbed to $13.62 million.
• Net working capital requirement covenant of $4 million met; next test 30 Nov 2025.

Cash flow

• Operating cash from continuing ops: $1.25 million, boosted by ERC and working-capital releases.
• Investing outflow: $0.21 million for capex; financing outflow: $1.04 million mainly line-of-credit pay-down.

Order backlog

• Combined backlog fell 39 % YoY to $4.73 million (Agricultural $0.86 m; Modular $3.87 m), signaling softer near-term visibility.

Outlook commentary

• Management expects Agricultural demand to improve as dealer inventory normalises and livestock margins remain strong.
• Modular Buildings pipeline remains active; expanded sales leadership aims to tap new research-facility markets.

Key takeaways: The quarter’s profitability is largely attributable to a non-recurring ERC benefit; underlying sales contracted and backlog declined. Nonetheless, lower leverage, higher gross margin and robust Modular Buildings profitability are constructive signs, while Agricultural Products remains pressured.